Download Colon Cancer/Colorectal Cancer

Survey
yes no Was this document useful for you?
   Thank you for your participation!

* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project

Document related concepts
no text concepts found
Transcript
BIOL 207 Biology of Cancer
Spring 2004
Lecture 16: "Colon Cancer"
Reading: Scientific American special issue pp. 92-93
Lecture:
1. Risk factors
2. Screening tests
3. Hereditary diseases associated with colon cancer
Path of digestion (organ system handout--digestive system)
 mouth
 pharynx
 esophagus
 stomach
 small intestine
 large intestine (colon, rectum, anus)
Colon cancer: Primary tumor colon or rectum, secondary tumor usually liver.
Second leading cancer killer after lung cancer.
Risk factors:
 heredity ~10% of cases
 presence of polyps= benign growths in intestinal lining
 smoking
 colitis or Crohn’s disease (diseases of GI tract)
 industrial or urban area?
 diet: high fiber, low fat?
Screening: general population: early detection
--digital rectal exam (age 40)
--fecal “hemoccult” test detects blood in stool (age 50--> every 5 yrs.)
hemoccult test
--watch diet (no red meat or fish) 3 days prior; no vitamin C, fresh broccoli,
cauliflower, aspirin
--test done on sample of stool, blue color indicates trace of blood in stool
--positive test must be rescreened for presence of cancer
other confirming tests
--sigmoidoscopy
--colonoscopy
--barium enema
1
Only 38% of colon cancers detected in early stages
Staging--Dukes classification
TNM staging: Major stages I, II, III, IV
Other markers of advanced cancer
--CEA: carcinoembryonic antigen
--DNA aneuploidy=missing or extra chromosomes
Treatment
 surgical resection: remove tumor from section of colon and stitch back
together; 75% cure rate
 chemotherapy or radiation therapy usually after surgery
 first FDA approved anti-angiogenesis drug for advanced (metastatic)
colon cancer is Avastin, a monoclonal antibody against VEGF (vascular
endothelial growth factor), developed by Genentech
Hereditary colon cancer

p53 tumor suppressor gene discovered by lab studying colon cancer (Dr.
Bert Vogelstein)

Other tumor suppressor genes specifically involved in hereditary colon
cancers
o APC gene: Responsible for hereditary FAP (famial adenomatous
polyposis); located on chromosome 5. In FAP, patients have many
polyps in colon and rectum. Mutations in APC initiate essentially all
colorectal tumors. The protein encoded by APC is most likely
involved in cell adhesion. Mutation of APC gene also leads to
overexpression of the c-myc oncogene.
o HNPCC gene: Gene responsible for hereditary nonpolyposis
colorectal cancer. Patients with hereditary HNPCC get one or a
few tumors of the colon. Due to defects in any of 6 genes; at least
four genes encode subunits of DNA repair enzymes. Two of these
genes are MSH2 and MLH1.
Future: Use gene tests for APC, HNPCC genes, p53 and/or the oncogene ras
for diagnosis, monitoring and possibly treatment of both hereditary and nonhereditary forms of colorectal cancer.
Video clip on hereditary colon cancer
2